We are live on
!
Find out more
BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.97B
1-Year Est. Return
44.96%
This Fund
S&P 500
This Quarter
Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.18B
AUM Growth
+$413M
(+11%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
7.01%
Top 10 Holdings %
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$20M |
| 2 |
NVIDIA
NVDA
|
+$19M |
| 3 |
Johnson & Johnson
JNJ
|
+$14.9M |
| 4 |
Coca-Cola
KO
|
+$14.6M |
| 5 |
Microsoft
MSFT
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TA
TravelCenters of America LLC
TA
|
+$21.5M |
| 2 |
PR
Permian Resources
PR
|
+$14.3M |
| 3 |
PBF Energy
PBF
|
+$12.6M |
| 4 |
Genworth Financial
GNW
|
+$11.6M |
| 5 |
Cigna
CI
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.63% |
| 2 | Consumer Discretionary | 12.15% |
| 3 | Technology | 12.08% |
| 4 | Industrials | 12% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Frequency Electronics
FEIM
$818M
| $142K | ﹤0.01% |
21,500
| – | – |
|
|
SBFM
1202
Sunshine Biopharma
SBFM
$3.4M
| $141K | ﹤0.01% |
14
| – | – |
|
1203
Cemtrex
CETX
$4.75M
| – | – |
0
| – | – |
|
|
TBHC
1204
DELISTED
The Brand House Collective
TBHC
| $140K | ﹤0.01% |
50,000
| – | – |
|
1205
LGL Group
LGL
$47M
| $139K | ﹤0.01% |
29,200
| – | – |
|
1206
Q32 Bio
QTTB
$480M
| $137K | ﹤0.01% |
8,617
-4,166
| -33% | -$74.8K |
|
1207
Exagen
XGN
$159M
| $137K | ﹤0.01% |
47,300
| – | – |
|
1208
Solid Biosciences
SLDB
$864M
| $137K | ﹤0.01% |
26,057
-8,629
| -25% | -$48.6K |
|
1209
Neuronetics
STIM
$159M
| $135K | ﹤0.01% |
63,005
-80,000
| -56% | -$194K |
|
1210
Douglas Elliman
DOUG
$162M
| $135K | ﹤0.01% |
60,600
-344,924
| -85% | -$947K |
|
|
KRON
1211
DELISTED
Kronos Bio
KRON
| $134K | ﹤0.01% |
77,800
-70,610
| -48% | -$112K |
|
1212
ARS Pharmaceuticals
SPRY
$544M
| $134K | ﹤0.01% |
19,944
| – | – |
|
1213
Magyar Bancorp
MGYR
$123M
| $130K | ﹤0.01% |
12,579
| – | – |
|
1214
Bolt Biotherapeutics
BOLT
$7.47M
| $130K | ﹤0.01% |
5,060
+1,300
| +35% | +$41.3K |
|
1215
Serina Therapeutics
SER
$35.4M
| $129K | ﹤0.01% |
4,116
-711
| -15% | -$15.2K |
|
1216
Precision BioSciences
DTIL
$192M
| $129K | ﹤0.01% |
8,180
-2,500
| -23% | -$57.2K |
|
|
FTH
1217
Faeth Therapeutics
FTH
$626M
| $129K | ﹤0.01% |
5,645
| – | – |
|
|
UBX
1218
DELISTED
Unity Biotechnology
UBX
| $128K | ﹤0.01% |
50,000
| – | – |
|
1219
Grove Collaborative
GROV
$46.7M
| $127K | ﹤0.01% |
+72,025
| New | +$158K |
|
1220
Aware
AWRE
$27.9M
| $127K | ﹤0.01% |
80,679
-50,000
| -38% | -$82.4K |
|
1221
ReposiTrak
TRAK
$156M
| $127K | ﹤0.01% |
+12,627
| New | +$94.9K |
|
1222
TScan Therapeutics
TCRX
$50.2M
| $125K | ﹤0.01% |
50,000
-65,000
| -57% | -$174K |
|
|
SYRS
1223
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $124K | ﹤0.01% |
39,500
-10,000
| -20% | -$32.1K |
|
|
VIA
1224
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $123K | ﹤0.01% |
+17,740
| New | +$212K |
|
1225
Lipocine
LPCN
$17.7M
| $123K | ﹤0.01% |
24,665
| – | – |
|
Similar funds
SNT
MA
FFB
AM
SGM
PAMP
SMFG
SIA
Bridgeway Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.
- Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
- Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
- Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
- Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
- Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
- Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
- Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.
Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.